Signs Of Long-Term Efficacy Boost UniQure’s Hem B Gene Therapy

Will Await Main Study’s One-Year Milestone Before Submission

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.